Literature DB >> 14514756

Activation of vanilloid receptor 1 (VR1) by eugenol.

B H Yang1, Z G Piao, Y-B Kim, C-H Lee, J K Lee, K Park, J S Kim, S B Oh.   

Abstract

The structural similarity of eugenol with capsaicin suggests that these two agents may share molecular mechanisms to produce their effects. We investigated the effects of eugenol in comparison with those of capsaicin using whole-cell patch clamp and Fura-2-based calcium-imaging techniques in a heterologous expression system and with sensory neurons. In vanilloid receptor 1 (VR1)-expressing human embryonic kidney (HEK) 293 cells and trigeminal ganglion (TG) neurons, eugenol activated inward currents, whereas capsazepine, a competitive VR antagonist, and ruthenium red (RR), a functional VR antagonist, completely blocked eugenol-induced inward currents. Moreover, eugenol caused elevation of [Ca(2+)](i), and this was completely abolished by both capsazepine and ruthenium red in VR1-expressing HEK 293 cells and TG neurons. Our results provide strong evidence that eugenol produces its effects, at least in part, via VR1 expressed by the sensory nerve endings in the teeth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14514756     DOI: 10.1177/154405910308201004

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  47 in total

1.  Characterizing the effects of Eugenol on neuronal ionic currents and hyperexcitability.

Authors:  Chin-Wei Huang; Julie Chi Chow; Jing-Jane Tsai; Sheng-Nan Wu
Journal:  Psychopharmacology (Berl)       Date:  2011-12-13       Impact factor: 4.530

2.  Eugenol dilates mesenteric arteries and reduces systemic BP by activating endothelial cell TRPV4 channels.

Authors:  Dieniffer Peixoto-Neves; Qian Wang; Jose H Leal-Cardoso; Luciana V Rossoni; Jonathan H Jaggar
Journal:  Br J Pharmacol       Date:  2015-05-19       Impact factor: 8.739

3.  Molecular basis of Ca(v)2.3 calcium channels in rat nociceptive neurons.

Authors:  Zhi Fang; Chul-Kyu Park; Hai Ying Li; Hyun Yeong Kim; Seong-Hae Park; Sung Jun Jung; Joong Soo Kim; Arnaud Monteil; Seog Bae Oh; Richard J Miller
Journal:  J Biol Chem       Date:  2006-12-04       Impact factor: 5.157

4.  Inhibitory effects of eugenol on putative nociceptive response in spinal cord preparation isolated from neonatal rats.

Authors:  Saki Yagura; Hiroshi Onimaru; Koji Kanzaki; Masahiko Izumizaki
Journal:  Exp Brain Res       Date:  2018-04-13       Impact factor: 1.972

5.  Targeting of sodium channel blockers into nociceptors to produce long-duration analgesia: a systematic study and review.

Authors:  D P Roberson; A M Binshtok; F Blasl; B P Bean; C J Woolf
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 6.  TRPV1: on the road to pain relief.

Authors:  Andrés Jara-Oseguera; Sidney A Simon; Tamara Rosenbaum
Journal:  Curr Mol Pharmacol       Date:  2008-11       Impact factor: 3.339

7.  Eugenol and carvacrol excite first- and second-order trigeminal neurons and enhance their heat-evoked responses.

Authors:  A H Klein; C L Joe; A Davoodi; K Takechi; M I Carstens; E Carstens
Journal:  Neuroscience       Date:  2014-04-20       Impact factor: 3.590

Review 8.  To flourish or perish: evolutionary TRiPs into the sensory biology of plant-herbivore interactions.

Authors:  Justyna B Startek; Thomas Voets; Karel Talavera
Journal:  Pflugers Arch       Date:  2018-09-18       Impact factor: 3.657

9.  Eugenol Inhibits ATP-induced P2X Currents in Trigeminal Ganglion Neurons.

Authors:  Hai Ying Li; Byung Ky Lee; Joong Soo Kim; Sung Jun Jung; Seog Bae Oh
Journal:  Korean J Physiol Pharmacol       Date:  2008-12-31       Impact factor: 2.016

Review 10.  Moving towards supraspinal TRPV1 receptors for chronic pain relief.

Authors:  Enza Palazzo; Livio Luongo; Vito de Novellis; Liberato Berrino; Francesco Rossi; Sabatino Maione
Journal:  Mol Pain       Date:  2010-10-11       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.